The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Merck; Sanofi
Travel, Accommodations, Expenses - Ipsen; MSD Oncology
Phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patients with muscle invasive bladder cancer ineligible or who refuse cisplatin-based chemotherapy: The PRISMA-1 study.
 
Ignacio Duran
Honoraria - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pfizer/EMD Serono; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer; Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Gilead Sciences; Ipsen; Pfizer/EMD Serono; Roche/Genentech
 
Miguel Climent Duran
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai Europe; EUSA Pharma; Ipsen; Janssen; Merck; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Merck; MSD Oncology; Pfizer; Roche
 
Iciar García Carbonero
No Relationships to Disclose
 
Angela Villares
No Relationships to Disclose
 
Ricardo Sánchez-Escribano
No Relationships to Disclose
 
Jesus Calleja
No Relationships to Disclose
 
Naiara Sagastibelza
No Relationships to Disclose
 
Ainara Villafruela
No Relationships to Disclose
 
Isabel Galante
No Relationships to Disclose
 
Jose Dominguez
No Relationships to Disclose
 
Albert Font Pous
Consulting or Advisory Role - Astellas Pharma; Bayer; Merck; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Merck; Novartis
 
Pol Servian
No Relationships to Disclose
 
Nuria Lainez
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD
Speakers' Bureau - Ipsen; Merck; MSD
 
Vicente Grasa
No Relationships to Disclose
 
Urbano Anido
Employment - GlaxoSmithKline (I); Leo P (I)
Honoraria - Bayer; Bristol-Myers Squibb; Eisai Europe; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Pfizer
Speakers' Bureau - AAA/Endocyte/Novartis; Bristol-Myers Squibb; Ipsen; Merck
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer; Roche; Sanofi; Sanofi
Other Relationship - LEO Pharma (I)
 
Anton Cimadevila
No Relationships to Disclose
 
Mario Dominguez
No Relationships to Disclose
 
Xavier Garcia del Muro
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Deciphera; Eisai; GlaxoSmithKline; Ipsen; Merck; MSD; Pfizer; PharmaMar; Recordati; Roche
Speakers' Bureau - Astellas Pharma; Eisai; Pfizer; Recordati
Research Funding - AstraZeneca; Incyte
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck; Pfizer
 
Oscar Buisan
No Relationships to Disclose
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Merck (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; MSD Oncology; Pfizer; Roche